Suchergebnisse - (Subject:"PARP inhibitor")

PubPharm (10)

1

A PARP1 PROTAC as a novel strategy against PARP inhibitor resistance via promotion of ferroptosis in p53-positive breast cancer

enthalten in: Biochemical pharmacology | 2022

von Li, G. | Lin, S. | Yu, Z. | +9

2

Resveratrol sensitizes breast cancer to PARP inhibitor, talazoparib through dual inhibition of AKT and autophagy flux

enthalten in: Biochemical pharmacology | 2022

von Pai Bellare, G. | Sankar Patro, B.

3

Evaluating the potential of kinase inhibitors to suppress DNA repair and sensitise ovarian cancer cells to PARP inhibitors

enthalten in: Biochemical pharmacology | 2019

von Mukhopadhyay, A. | Drew, Y. | Matheson, E. | +4

4

Mitotic functions of poly(ADP-ribose) polymerases

enthalten in: Biochemical pharmacology | 2019

von Slade, D.

5

Enabling drug discovery for the PARP protein family through the detection of mono-ADP-ribosylation

enthalten in: Biochemical pharmacology | 2019

von Lu, A. | Abo, R. | Ren, Y. | +6

6

PARPs and PAR as novel pharmacological targets for the treatment of stress granule-associated disorders

enthalten in: Biochemical pharmacology | 2019

von Grimaldi, G. | Catara, G. | Palazzo, L. | +3

7

Influence of onconase in the therapeutic potential of PARP inhibitors in A375 malignant melanoma cells

enthalten in: Biochemical pharmacology | 2019

von Raineri, A. | Prodomini, S. | Fasoli, S. | +2

8

Therapeutic considerations of PARP in stem cell biology : Relevance in cancer and beyond

enthalten in: Biochemical pharmacology | 2019

von Zeniou, M. | Nguekeu-Zebaze, L. | Dantzer, F.

9

Targeting ADP-ribosylation by PARP inhibitors in acute myeloid leukaemia and related disorders

enthalten in: Biochemical pharmacology | 2019

von Faraoni, I. | Giansanti, M. | Voso, M. | +2

10

Poly (ADP-ribose) polymerases inhibitor, Zj6413, as a potential therapeutic agent against breast cancer

enthalten in: Biochemical pharmacology | 2016

von Zhou, Q. | Ji, M. | Zhou, J. | +5

1
[1]